“The aseptic samplings market is projected to grow at a CAGR of 13.5%.”
The aseptic samplings market is expected to reach 1,247.0 million by 2023 from USD 662.1 million in 2018 at a CAGR of 13.5%. The rising demand for biopharmaceuticals and advantages of single-use aseptic sampling and bioprocessing products such as reduced cost of installation, decreased risk of product cross-contamination, and fast implementation are driving the aseptic sampling market. On the other hand, issues related to the transfer of leachables and extractables into the solvent which can cause contamination are the major factors restraining the growth of this market.

“The bags product segment is expected to account for the largest share in 2018.”
On the basis of type, aseptic sampling market is classified into manual aseptic sampling and automatic aseptic sampling. Manual aseptic sampling market on the basis of product, is segmented into bags, bottles, syringes, and accessories. In 2018, the bags segment is expected to account for the largest share of the manual aseptic sampling market. Single-use bags are convenient to use, easy to connect, and eliminate the need for manual cleaning processes. Their widespread and growing applications have also supported the growth of this market segment.

“The Europe is expected to account for the largest share in 2018.”
Among the four geographic regions, Europe is expected to account for the largest share of the aseptic sampling market in 2018, followed by North America, APAC, and the RoW. The large share of Europe in this market is majorly attributed to the patent cliff of many biologic drugs in the region. As a result, several companies in Europe are engaged in research activities for the development of novel drug products. Moreover, governments in several European countries are supporting pharmaceutical companies to launch new biologic therapies that offer superior efficacy than traditional drugs. This in turn is increasing the number of R&D activities in the region. Aseptic sampling products help manufacturers to eliminate the risk of contamination and follow GMP guidelines for the aseptic manufacturing of drugs. Aseptic sampling systems help in reducing initial investments and are suitable for R&D; these advantages are driving their higher uptake.

Break-up profile of primaries:

  • By Company Type- Tier 1-40%, Tier 2-30% and Tier 3-30%
  • By Designation-C-level-27%, D-level-18% and Others-55%
  • By Region-North America-50%, Europe-20%, Asia-20%, and RoW-10%

The key players in the aseptic samplings market are Sartorius Stedim Biotech (France), Merck Millipore (Germany), Danaher (US), and Thermo Fisher Scientific (US).

Research Coverage:
The aseptic samplings market in this report is segmented by type, technique, application, end user, and region. The study tracks and analyzes competitive developments such collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the aseptic samplings market.

Reasons To buy this report:
The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global aseptic samplings market. The report analyzes the market by type, technique, application, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the aseptic samplings market
  • Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for aseptic sampling products across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global aseptic samplings market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global aseptic samplings market